End-Stage Renal Disease: CMS Should Monitor Access to and Quality of Dialysis Care Promptly After Implementation of New Bundled Payment System

Front Cover
DIANE Publishing, 2011 - 72 pages
0 Reviews
This is a print on demand edition of a hard to find publication. Medicare covers dialysis for most individuals with end-stage renal disease (ESRD). Beginning Jan. 2011, the Centers for Medicare and Medicaid Services (CMS) must use a single payment to pay for dialysis and related services, which include injectable ESRD drugs. What is this new payment system's effects on the access to and quality of dialysis care for certain groups of beneficiaries? This report examined: (1) Medicare expend. for injectable ESRD drugs, by demographic characteristics; (2) factors likely to result in above average doses of these drugs; (3) CMS's approach for addressing beneficiary differences in the cost of dialysis care under the new payment system; and (4) CMS's plans to monitor the new payment system's effects. Charts and tables.

What people are saying - Write a review

We haven't found any reviews in the usual places.

Common terms and phrases

Bibliographic information